Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The degree to which viral infection and the host's immune reaction to viral particles participate in the inflammatory process across various forms of herpetic keratitis has remained controversial. This fact has created conflicts regarding the classification of and therapeutic planning for such morbidities. This review aims to stimulate reflection on the classifications' adequacy, nomenclatures, and therapeutic approaches related to these entities.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11878438 | PMC |
| http://dx.doi.org/10.5935/0004-2749.20210082 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Insights of Kaposi's Varicelliform Eruption Associated with Underlying Primary Dermatoses- A Case Series from Hadoti Region of Rajasthan.
Indian J Dermatol
September 2025
From the Department of Dermatology, Venereology and Leprosy, GMC, Kota, Rajasthan, India.
Eczema Herpeticum (EH) or Kaposi's Varicelliform eruption (KVE) is a severe viral infection that occurs when herpes simplex virus infects an inflamed skin, most often occurring in patients with atopic dermatitis (AD) or other inflammatory skin conditions. To discern various primary dermatoses in which KVE occurred and to study the clinical features, course, and response to specific antiviral treatment along with a course of the primary dermatoses during the episode of KVE. Data was collected in the Dermatology Out-patient department of a tertiary care center in Northern India from December 2017 to March 2024, and it was tabulated and analysed.
View Article and Find Full Text PDFBroad-spectrum therapeutic potential of 4-phenylbutyrate in neurological and systemic diseases of viral and non-viral origin.
Front Pharmacol
August 2025
Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL, United States.
4-Phenylbutyrate (4-PBA), initially recognized for treating urea cycle disorders, has emerged as a potent therapeutic agent with broad-spectrum potential. As a chemical chaperone, 4-PBA modulates protein folding and reduces endoplasmic reticulum stress. 4-PBA has demonstrated efficacy in treating ocular herpes simplex virus type 1 (HSV-1) infection and HSV-1-induced encephalitis, highlighting its potential as a novel anti-herpetic therapy.
View Article and Find Full Text PDFBetrixaban is a broad anti-virus inhibitor by activating innate immunity.
Front Cell Infect Microbiol
September 2025
Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, China.
The innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses, leading to broad-spectrum antiviral effects.
View Article and Find Full Text PDFInactivation of BSL-2 and BSL-3 human pathogens using FATHHOME's Trinion Disinfector: A rapid and eco-friendly ozone-based dry disinfection approach.
Biosaf Health
August 2025
Department of Microbiology and Immunology, University of Nevada, Reno School of Medicine, MS320, Reno 89557 Nevada, United States of America.
The role of personal protective equipment (PPE) in protecting against exposure to infectious agents and toxic chemicals is well-established. However, the global surge in PPE demand during the pandemic exposed challenges, including shortages and environmental impacts from disposable waste. Developing effective, scalable, and sustainable decontamination methods for the reuse of PPE is essential.
View Article and Find Full Text PDFIRF6 Enhances IFN-β Expression and Inhibits Viral Replication to Reduce the Severity of Herpetic Stromal Keratitis.
J Inflamm Res
September 2025
Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Purpose: Herpes simplex virus type 1 (HSV-1) infection of the human eye can lead to herpes simplex keratitis, which is the leading cause of infectious blindness worldwide. Inflammation invading the corneal stroma causes herpetic stromal keratitis (HSK). Interferon regulatory factor 6 (IRF6) is a member of the interferon regulatory factor family and is involved in the antiviral response against human papillomavirus 16.
View Article and Find Full Text PDF